Neogi, U.; Ambikan, A. T.; Turkowski, K.; Schneider, M. A.; Beutgen, V. M.; Graumann, J.; Winter, H.; Bartkuhn, M.; Seeger, W.; Pullamsetti, S. S.et al.; Savai, R.: Plasma proteomic profiling and molecular clustering reveal immune-defined prognostic subtypes in lung adenocarcinoma. INTERNATIONAL JOURNAL OF CANCER (2025)
Turkowski, K.; Brandenburg, S.; Mueller, A.; Kremenetskaia, I.; Bungert, A. D.; Blank, A.; Felsenstein, M.; Vajkoczy, P.: VEGF as a modulator of the innate immune response in glioblastoma. GLIA 66 (1), pp. 161 - 174 (2018)
Turkowski, K.; Haselbauer, T.; Kaduthanam, S.; Sueltmann, H.; Grimminger, F.; Seeger, W.; Savai, R.: Macrophage and Cancer Cell Crosstalk Regulated MicroRNA 147b Plays a Crucial Role in Lung Cancer Progression. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 197 (2018)
Zheng, X.; Turkowski, K.; Mora, J.; Brne, B.; Seeger, W.; Weigert, A.; Savai, R.: Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. ONCOTARGET 8 (29), pp. 48436 - 48452 (2017)
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).
Institutions from the Rhine-Main region have come together in Frankfurt's Römer to form a new science network. The future cooperation in the "Frankfurt Alliance" was sealed with the signing of a Memorandum of Understanding. The Max Planck Institute for Heart and Lung Research is one of the founding members of the new scientific alliance.